Drug Trial Radar · NCT07086313
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
Last checked: Nov 19, 2026Latest source record: Dec 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
315
Planned (sponsor's estimate)
Start
Sep 3, 2025
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.Otsuka
- Sponsor type
- Industry
- First posted
- Jul 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 6 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and examine the safety of two doses of EB-1020 QD XR capsule administered once daily orally in pediatric ADHD patients.
Conditions
- Attention-Deficit Hyperactivity Disorder(ADHD)
Interventions
EB-1020 (Centanafadine) low doseDrug
low dose, capsule, oral, once daily, for 6 weeks
EB-1020 (Centanafadine) high doseDrug
high dose, capsule, oral, once daily, for 6 weeks
PlaceboDrug
Placebo, capsule, oral, once daily, for 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in ADHD-RS-5 symptom total raw score at Week 6.Time frame: Baseline, Weeks 6
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hokkaido University Hospital
Sapporo, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.